⚖UPC-Intel
🇪🇺 UPC

UPC_CFI_552/2025

Court
Milan Central Division (Section)
Type of action
revocation
Patent
USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION
Language
en
Claimant / applicant
  • Gilead Sciences, Inc.
Defendant / respondent
  • Academy of Military Medical Sciences

Track this case

Get an email when a new order or decision is published in UPC_CFI_552/2025.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.